NASDAQ$LUNG

Pulmonx Corporation · Q1 2021 earnings

Q1 2021 earnings · · Investor relations

Briefing

Pulmonx reported a 7% increase in worldwide revenue, reaching $9.2 million, and a gross margin of 71.5% compared to 65.6% in the same period last year.

Pulmonx Corporation reported a 7% increase in worldwide revenue for the first quarter of 2021, totaling $9.2 million. The company experienced a gross margin of 71.5%, an increase from 65.6% in the same period last year. While U.S. revenue decreased by 5%, international revenue rose by 20%.

  • Worldwide revenue increased by 7% to $9.2 million in the first quarter of 2021.
  • Gross margin improved to 71.5% in the first quarter of 2021.
  • U.S. revenue decreased by 5% due to the impact of the COVID-19 pandemic.
  • International revenue increased by 20%, driven by a recovery of procedures in select markets.

Headline financials

Total Revenue

$9.24M

Previous: $8.62M+7.3%
EPS (adj)

-$0.34

Previous: -$37.60+99.1%
Capital Expenditures

-$242K

Previous: $81K-398.8%
Free Cash Flow

-$12.3M

Previous: -$9.93M-23.7%
Net Income

-$12M

Previous: -$7.16M-68.2%
Operating Income

-$12M

Previous: -$6.1M-97.0%
Gross Profit

$6.61M

Previous: $5.65M+17.0%
Cash & Equivalents

$209M

Previous: $16.2M+1188.6%
Total Assets

$255M

No prior period
Stock-Based Comp

$2.27M

Previous: $209K+985.2%

Revenue & EPS history

Pulmonx · Revenue · Quarterly

$9.24M

Q1 2021+7.3%vs Q1 2020
Beat estimate in 6 of 10 quarters(60%)
ActualEstimate

Forward guidance

Pulmonx is updating full year 2021 revenue to be in the range of $48 to $50 million and expects total operating expenses for the full year 2021 to remain in the range of $85 million to $90 million inclusive of stock-based compensation.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2021

Historical avgQ1 2021

-3.4%

Avg return

Earnings day

-4.1%

Avg return

5 days after

-5.3%

Avg return

30 days after

42%

10 / 24 earnings

Positive

+32.2%

Q4 2024

Best reaction

-64.7%

Q3 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.5%-6.7%+12.6%
Q4 2025+0.6%-6.1%-28.2%
Q3 2025-18.9%-28.6%+29.1%
Q1 2025-21.9%-28.8%-29.6%
Q4 2024+32.2%+30.7%+17.0%
Q3 2024-7.7%+5.2%-4.7%
Q2 2024-8.1%-15.4%+3.7%
Q1 2024+23.3%+21.9%-4.7%
Q4 2023-17.7%-27.9%-36.1%
Q3 2023+6.9%+20.7%+34.2%
Q2 2023-4.1%-8.0%-26.0%
Q1 2023+1.1%-0.2%-1.5%
Q4 2022+20.8%+26.0%+27.1%
Q3 2022-64.7%-61.1%-52.3%
Q2 2022+9.2%+19.9%+5.7%
Q1 2022+0.6%-23.6%-23.9%
Q4 2021-6.9%-2.5%-12.5%
Q3 2021+7.1%+12.6%-23.7%
Q2 2020-7.6%-10.9%-1.6%
Q2 2021+0.1%+6.0%+3.3%
Q1 2020-5.8%-5.3%+9.9%
Q1 2021-8.7%-9.6%-10.3%
Q4 2020-4.1%-3.4%-20.2%
Q3 2020-4.9%-3.4%+5.6%
Q4 2019
Q3 2019
Q2 2019
Q1 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro